The immunologic response to severe traumatic injury is complex - such that individual patients may face exceptionally different immunologic challenges at different points in time. It is in this context that one must consider potentially additive immunomodulatory effects of blood product transfusion. This review will consider first the immunologic response to traumatic injury, followed by the epidemiology and outcomes related to blood product transfusion in trauma patients, and lastly immunologic effects of transfusion in the context of trauma. (C) 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2nutn0J
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Lack of standard definitions of primary and secondary (non)responders after RYGB and SG makes it impossible to compare the litera...
-
Objective We examined whether teleconsultation from ambulances to a physician at an emergency medical communication center (EMCC) would incr...
-
AbstractIntroductionVascular trauma data have been submitted to the American Association for the Surgery of Trauma PROspective Observational...
-
FDA approves Elzonris for blastic plasmacytoid dendritic cell neoplasm https://www.mdedge.com/hematologynews/article/191723/rare-diseases/...
-
Publication date: December 2018 Source: The Journal of Emergency Medicine, Volume 55, Issue 6 Author(s): Adam Esch from Emergency Medi...
-
Note: Page numbers of article titles are in boldface type. from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2aggaBB
-
Abstract dsfIntroduction Cannabis legalization in Colorado resulted in increased cannabis-associated healthcare utilization. Our objecti...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου